Enhabit receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Enhabit Inc (EHAB)
Enhabit Inc stock price live, this page displays NYSE EHAB stock exchange data. View the EHAB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Enhabit Inc real time stock price chart below.
What Is the Enhabit Inc Stock Price Today?
The Enhabit Inc stock price today is 7.56.
What Is the Stock Symbol for Enhabit Inc?
The stock symbol for Enhabit Inc is ""EHAB.""
What Stock Exchange Does Enhabit Inc Trade On?
Enhabit Inc is listed and trades on the NYSE stock exchange.
Is Enhabit Inc a Good Stock to Buy?
Determining whether Enhabit Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EHAB quote. (ISIN: US29332G1022)
What Is the Enhabit Inc Stock Price Today?
The Enhabit Inc stock price today is 7.56.
What Is the Stock Symbol for Enhabit Inc?
The stock symbol for Enhabit Inc is ""EHAB.""
What Stock Exchange Does Enhabit Inc Trade On?
Enhabit Inc is listed and trades on the NYSE stock exchange.
Is Enhabit Inc a Good Stock to Buy?
Determining whether Enhabit Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EHAB quote. (ISIN: US29332G1022)
NYSE
Currency in USD
Fair Value
An estimate of a Enhabit's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.44
7.66
52 wk Range
6.47
10.91
EHAB Scorecard
Full Analysis
High shareholder yield
EHAB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Enhabit's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.447.66
52 wk Range
6.4710.91
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EHAB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Enhabit's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
9.38
Upside
+24.01%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Form 8K Enhabit Inc For: 26 June
- Investing.com
- Enhabit receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Enhabit CEO Barb Jacobsmeyer to step down in 2026
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Enhabit Inc Company Profile
Enhabit, Inc. provides home health and hospice services in the United States. The company’s home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. It also provides hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Enhabit Inc Earnings Call Summary for Q2/2025
- Q2 2025 EPS of $0.13 beat estimates by 30%, revenue of $266.1M exceeded forecast; stock surged 15.07% to $7.15
- Hospice revenue grew 19.4% YoY; company focuses on operational efficiency and debt reduction amid industry challenges
- Full-year guidance: revenue $1.060B-$1.073B, adjusted EBITDA $104M-$108M; concerns over proposed 6.4% rate cut for 2026
- CEO transition planned for 2026; company leveraging size, scale, and technology investments to address market challenges
- Payer contract renegotiations resulted in low double-digit rate increase; strategies to mitigate CMS cuts discussed in Q&A
Last Updated: 07/08/2025, 19:48
Read Full TranscriptCompare EHAB to Peers and Sector
Metrics to compare | EHAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEHABPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.9x | −0.1x | −0.5x | |
PEG Ratio | 0.00 | 0.01 | 0.00 | |
Price/Book | 0.7x | 1.1x | 2.6x | |
Price / LTM Sales | 0.4x | 1.1x | 3.3x | |
Upside (Analyst Target) | 19.0% | 30.6% | 40.1% | |
Fair Value Upside | Unlock | 9.2% | 5.1% | Unlock |
Analyst Ratings
1 Buy
4 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 9.38
(+24.01% Upside)
Earnings
Latest Release
Aug 06, 2025
EPS / Forecast
0.13 / 0.10
Revenue / Forecast
266.10M / 263.39M
People Also Watch
FAQ
What Stock Exchange Does Enhabit Trade On?
Enhabit is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Enhabit?
The stock symbol for Enhabit is "EHAB."
What Is the Enhabit Market Cap?
As of today, Enhabit market cap is 383.22M.
What Is Enhabit's Earnings Per Share (TTM)?
The Enhabit EPS (TTM) is -2.64.
When Is the Next Enhabit Earnings Date?
Enhabit will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is EHAB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Enhabit Stock Split?
Enhabit has split 0 times.
How Many Employees Does Enhabit Have?
Enhabit has 10700 employees.
What is the current trading status of Enhabit (EHAB)?
As of 17 Aug 2025, Enhabit (EHAB) is trading at a price of 7.56, with a previous close of 7.39. The stock has fluctuated within a day range of 7.44 to 7.66, while its 52-week range spans from 6.47 to 10.91.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.